UPDATE 1-Sanofi diabetes drug Toujeo wins EU green light, pricing in focus

* Pricing seen key in determining Toujeo take-up (Adds product details, debate on pricing)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.